Dual Site-Selective Presentation of Functional Handles on Protein-Engineered Cowpea Chlorotic Mottle Virus-Like Particles.
Journal
Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319
Informations de publication
Date de publication:
19 05 2021
19 05 2021
Historique:
pubmed:
17
4
2021
medline:
14
9
2021
entrez:
16
4
2021
Statut:
ppublish
Résumé
Protein cages hold much promise as carrier systems in nanomedicine, due to their well-defined size, cargo-loading capacity, and inherent biodegradability. In order to make them suitable for drug delivery, they have to be stable under physiological conditions. In addition, often surface modifications are required, for example, to improve cell targeting or reduce the particle immunogenicity by PEGylation. For this purpose, we investigated the functionalization capacity of the capsid of cowpea chlorotic mottle virus (CCMV), modified at the interior with a stabilizing elastin-like polypeptide (ELP) tag, by employing a combination of protein engineering and bio-orthogonal chemistry. We first demonstrated the accessibility of the native cysteine residue in ELP-CCMV as a site-selective surface-exposed functional handle, which was not available in the native CCMV capsid. An additional bio-orthogonal functional handle was introduced by incorporation of the noncanonical amino acid, azido-phenylalanine (AzF), using the amber suppression mechanism. Dual site-selective presentation of both a cell-penetrating TAT peptide and a fluorophore to track the particles was demonstrated successfully in HeLa cell uptake studies.
Identifiants
pubmed: 33861931
doi: 10.1021/acs.bioconjchem.1c00108
pmc: PMC8154214
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
958-963Références
Chem Asian J. 2018 Nov 16;13(22):3518-3525
pubmed: 29975459
Pharm Res. 2016 Oct;33(10):2373-87
pubmed: 27299311
Annu Rev Virol. 2015 Nov;2(1):379-401
pubmed: 26958921
Curr Top Microbiol Immunol. 2009;327:v-vi
pubmed: 19198567
Bioconjug Chem. 2018 Apr 18;29(4):1186-1193
pubmed: 29406698
J Virol Methods. 2007 Dec;146(1-2):311-6
pubmed: 17804089
Bioconjug Chem. 2015 Dec 16;26(12):2429-34
pubmed: 26505648
Structure. 1995 Jan 15;3(1):63-78
pubmed: 7743132
Adv Drug Deliv Rev. 2020;156:214-235
pubmed: 32603813
Nat Chem. 2016 Feb;8(2):103-13
pubmed: 26791892
Bioeng Transl Med. 2019 Sep 05;4(3):e10143
pubmed: 31572799
Biomed Res Int. 2019 Oct 29;2019:4630891
pubmed: 31781617
Small. 2006 Aug;2(8-9):962-6
pubmed: 17193150
Biomacromolecules. 2009 Nov 9;10(11):3141-7
pubmed: 19839603
J Am Chem Soc. 2009 Dec 16;131(49):17771-3
pubmed: 19995072
J Am Chem Soc. 2012 Nov 14;134(45):18506-9
pubmed: 23101937
Bioconjug Chem. 2019 Dec 18;30(12):3069-3077
pubmed: 31765129
J Am Chem Soc. 2009 Aug 12;131(31):11174-8
pubmed: 19603808
J Am Chem Soc. 2017 Feb 1;139(4):1512-1519
pubmed: 28055188
Adv Drug Deliv Rev. 2013 Oct;65(10):1284-98
pubmed: 24018362
Chem Commun (Camb). 2002 Oct 21;(20):2390-1
pubmed: 12430455
Biomacromolecules. 2014 Feb 10;15(2):558-63
pubmed: 24359088
Int J Nanomedicine. 2007;2(4):715-33
pubmed: 18203438
Adv Virus Res. 2017;97:1-60
pubmed: 28057256
Curr Opin Biotechnol. 2004 Dec;15(6):513-7
pubmed: 15560977
Virology. 1995 Mar 10;207(2):486-94
pubmed: 7886952
Chem Commun (Camb). 2014 Apr 18;50(30):4007-9
pubmed: 24592400